Abstract
Pandemics caused by viruses such as SARS-CoV-2, which present high and quick spreading, highlight the emergency for the development of efficient treatments against this and other diseases. Peptides and bioconjugates have been showing promissory results as antivirals, inhibiting different steps of the virus life cycle. Peptides are advantageous compared to small molecules due to their high…